NSF Plan to Fund Center Surprises Two 'Partners'

WASHINGTON—National Science Foundation officials are hoping that an arranged marriage between Duke University and the National Institutes of Health will extend NSF's engineering research centers into the life sciences and provide a model for other joint ventures by federal research agencies. But progress has been slow because, as with most such marriages, the couple was the last to know. This spring the National Science Board agreed to spend up to $32 million over the next five years to cr

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

This spring the National Science Board agreed to spend up to $32 million over the next five years to create engineering centers at the University of Colorado and UCLA, bringing the total to 13 since the program was begun in 1985. It announced that Duke University's proposal for a center on emerging cardiovascular technologies would be next—if NIH agreed to put up at least one-third of the $14 million in federal funds being requested.

"President Reagan's 'Quest for Excellence' program calls on all federal agencies to become involved in various types of science and technology centers," said Mary Clutter, senior science adviser at NSF, in explaining why the board solicited NIH participation. "In addition, our charter says that we won't support clinically related, or disease-related, research. Although the Duke proposal is really about biomedical engineering," she said, "their application acknowledges that the impact of the research will be felt on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies